Cero Therapeutics Holdings, Inc. (CERO): Dividends Per Share

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2025-08-22. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

$10.37

Year ended 2025-12-31

Period ended	Dividends Per Share	Change YoY	Source filing
2025-12-31	$10.37	n/a	2026-04-15, From 2025-01-01

Dividends Per Share at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Dividends Per Share	Change YoY
Cero Therapeutics Holdings, Inc. (CERO)	2025-12-31	$10.37	n/a
enGene Therapeutics Inc. (ENGN)	2025-10-31	$0.00	n/a
Tectonic Therapeutic, Inc. (TECX)	2025-12-31	$0.00	n/a
Allogene Therapeutics, Inc. (ALLO)	2025-12-31	$0.00	n/a
Tarsus Pharmaceuticals, Inc. (TARS)	2025-12-31	$0.00	n/a
Immunocore Holdings plc (IMCR)	2025-12-31	$0.00	n/a
Bio-Techne Corp (TECH)	2026-06-30	$0.32	0.0%
Vaxcyte, Inc. (PCVX)	2025-12-31	$0.00	n/a
Qiagen N.V. (QGEN)	2025-12-31	$0.25	n/a

Compare CERO, ENGN, TECX, ALLO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗